Pharvaris N.V. Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Share-based Payment Arrangement2019
Pharvaris N.V. (PHVS) had Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Share-based Payment Arrangement2019 of 0 EUR/shares as of 2022-12-31, per its 20-F filed 2023-04-05.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 · last filed 2023-04-05
- 2022-12-31: Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Share-based Payment Arrangement2019 0.00 EUR/shares.
- 2021-12-31: Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Share-based Payment Arrangement2019 0.00 EUR/shares.
- 2020-12-31: Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Share-based Payment Arrangement2019 0.00 EUR/shares.
- 2019-12-31: Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Share-based Payment Arrangement2019 0.01 EUR/shares.
| Period end | Weighted Average Exercise Price Of Other Equity Instruments Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2022-12-31 | 0.00 EUR/shares 20-F · filed 2023-04-05 |
| 2021-12-31 | 0.00 EUR/shares 20-F · filed 2023-04-05 |
| 2020-12-31 | 0.00 EUR/shares 20-F · filed 2023-04-05 |
| 2019-12-31 | 0.01 EUR/shares 20-F · filed 2022-03-29 |
| 2018-12-31 | 0.01 EUR/shares 20-F · filed 2021-04-29 |